Winton Group LTD Pacira Bio Sciences, Inc. Transaction History

Winton Group LTD

$1.72 Billion
Q2 2025

A detailed history of Winton Group LTD transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Winton Group LTD holds 102,668 shares of PCRX stock, worth $2.17 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

102,668

Holding current value

$2.17 Million

% of portfolio

0.14%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$22.91 - $27.14 $2.35 Million - $2.79 Million	102,668 New	102,668 $2.45 Million
Q2 2024 Aug 09, 2024	BUY	$25.5 - $31.51 $2.43 Million - $3 Million	95,266 New	95,266 $2.73 Million
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $503,076 - $756,788	13,173 New	13,173 $508,000
Q4 2021 Feb 10, 2022	SELL	$47.97 - $62.21 $356,752 - $462,655	-7,437 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$54.64 - $61.3 $167,089 - $187,455	-3,058 Reduced 29.14%	7,437 $416,000
Q2 2021 Aug 10, 2021	SELL	$59.18 - $69.99 $182,274 - $215,569	-3,080 Reduced 22.69%	10,495 $637,000
Q1 2021 Jul 21, 2021	BUY	$59.31 - $78.82 $166,661 - $221,484	2,810 Added 26.1%	13,575 $951,000
Q4 2020 Feb 12, 2021	SELL	$50.47 - $66.26 $334,717 - $439,436	-6,632 Reduced 38.12%	10,765 $644,000
Q3 2020 Oct 30, 2020	SELL	$51.97 - $63.0 $3.4 Million - $4.12 Million	-65,405 Reduced 78.99%	17,397 $1.05 Million
Q2 2020 Aug 05, 2020	SELL	$30.8 - $52.47 $1.88 Million - $3.2 Million	-61,022 Reduced 42.43%	82,802 $4.35 Million
Q1 2020 May 11, 2020	SELL	$28.4 - $50.7 $505,804 - $902,967	-17,810 Reduced 11.02%	143,824 $4.82 Million
Q4 2019 Feb 13, 2020	BUY	$36.31 - $46.83 $4.25 Million - $5.48 Million	117,039 Added 262.45%	161,634 $7.32 Million
Q3 2019 Nov 08, 2019	BUY	$35.66 - $44.99 $1.59 Million - $2.01 Million	44,595 New	44,595 $1.7 Million

Others Institutions Holding PCRX

# of Institutions

261

Shares Held

51.2M

Call Options Held

289K

Put Options Held

130K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $967M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account